|
|
Volumn 6, Issue , 2016, Pages
|
|
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice (Scientific Reports (2016) 6 (26428))
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
|
|
EID: 84977633501
PISSN: None
EISSN: 20452322
Source Type: Journal
DOI: 10.1038/srep28124 Document Type: Erratum |
|
Times cited : (2)
|
|
References (0)
|